期刊文献+

老年男性代谢综合征患者血睾酮水平与骨密度及骨转换指标的相关性研究 被引量:3

The correlation between serum testosterone and bone mineral density and bone turnover markers in aged male patients with metabolic syndrome
下载PDF
导出
摘要 目的分析老年男性代谢综合征(MS)患者血睾酮(T)水平与骨密度(BMD)及骨转换指标之间的相互关系。方法收集60~90岁老年男性111例,分为MS组(61例)和非MS组(50例)。测定T、N-MID骨钙素(N-MID-OC)、总I型胶原氨基端延长肽(PINP)、血清β-胶原特殊系列(β-CTX)水平,同时使用双能X线骨密度测量仪测量左前臂、左髋部及腰椎的BMD,分析血清T水平与BMD及骨转换指标的相关性。结果 MS组的T、N-MID-OC、PINP、腰椎、髋骨及桡骨BMD水平均低于非MS组(P<0.05),β-CTX高于非MS组(P<0.05),且随着MS组分的增加,血T、N-MID-OC、PINP水平及腰椎、髋部、桡骨BMD平逐渐下降,β-CTX逐渐增高,差异有统计学意义(P<0.05)。相关性分析表明:血清T与N-MID-OC、PINP及腰椎、髋部、桡骨BMD呈正相关,与β-CTX水平呈负相关(P<0.05)。结论老年男性MS患者中血T水平与BMD及骨转换指标密切相关,低T水平可作为老年男性骨质疏松(OP)的预测因子。 Objective To investigate the relationship between serum testosterone(T)levels and parameters of bone mineral density(BMD)and bone turnover markers in aging male patients with metabolic syndrome(MS).Methods One hundred and eleven aged 60-90 years male patients were divided into two groups,namely MS group(sixty-one)and non-MS group(fifty).Serum T,N-MID-Osteocalcin(N-MID-OC),total type I collagen N-terminal extension peptide(PINP),serum β-collagen special series(β-CTX)levels were measured,and left forearm,left hip and lumbar vertebrae BMD were detected by dual energy X-ray densitometer.The relationship between T levels and parameters of BMD and bone turnover markers was analysed.Results T,N-MID-OC,PINP,left forearm BMD,left hip BMD,lumbar vertebrae BMD levels were lower andβ-CTX level were higher in MS group than those in non-MS group(P0.05).As the increase of MS contents,serum T,N-MID-OC,PINP levels and lumbar vertebrae BMD,hip BMD,forearm BMD decreased gradually,and β-CTX level increased.In MS group,there were significant positive correlation respectively between the levels of T and N-MID-OC,PINP,lumbar vertebrae BMD,hip BMD,forearm BMD.There was a negative relationship between the levels of serum T and β-CTX.Conclusion Serum T level is closely related to BMD and biochemical markers of bone turnover in aged male patients with metabolic syndrome.Lower serum T level may be an the independent factor for osteoporosis in aged men.
出处 《中国临床保健杂志》 CAS 2012年第1期36-39,共4页 Chinese Journal of Clinical Healthcare
基金 安徽省科技计划项目(08020303073)
关键词 代谢综合征 骨密度 睾酮 骨质疏松 男人 老年人 Metabolic syndrome Bone density Testosterone Osteoporosis Men Aged
  • 相关文献

参考文献14

  • 1Meier C,Nguyen TV,David J,et al.Endogenous sex hor-mones and incident fracture risk in older men[J].ArchIntern Med,2008,168(1):47-54.
  • 2Mellstrm D,Johnell O,Ljunggren O,et al.Free testoster-one is an independent predictor of BMD and prevalentfractures in elderly men:MrOS Sweden[J].J Bone MinerRes,2006,21(4):529-535.
  • 3康冬梅,叶山东.中老年男性血清睾酮水平与代谢综合征的相关性[J].医学综述,2011,17(17):2669-2671. 被引量:3
  • 4Haring R,Volzke H,Felix SB.Prediction of metabolicsyndrome by low serum testosterone levels in men:resultsfrom the study of health in Pomerania[J].Diabetes,2009,58(9):2027-2031.
  • 5Chu LW,Tam S,Kung AW,et al.Serum total and bio-available testosterone levels,central obesity,and musclestrength changes with aging in healthy Chinese men[J].Journal of the American Geriatrics Society,2008,56(7):1286-1291.
  • 6朱炜.骨质疏松症患者职业特征的调查与护理干预[J].浙江临床医学,2006,8(5):553-554. 被引量:3
  • 7彭永德,张颖.甲状旁腺素类似物在骨质疏松症治疗中的应用[J].中国临床保健杂志,2006,9(1):85-87. 被引量:2
  • 8杜红巧,马骏.骨质疏松与营养[J].中国临床保健杂志,2009,12(3):335-336. 被引量:8
  • 9Isidori AM,Giannetta E,Pozza C,et al.Androgens,cardi-ovascular disease and osteoporosis[J].J Endocrinol In-vest,2005,28(10 Suppl):73-79.
  • 10Szulc P,Varennes A,Delmas PD,et al.Men with metabol-ic syndrome have lower bone mineral density but lowerfracture risk:the MINOS study[J].J Bone Miner Res,2010,25(6):1446-1454.

二级参考文献48

  • 1朱冰,徐慧兰.原发性骨质疏松症可控危险因素的流行病学研究进展[J].中国医师杂志,2005,7(S1):473-476. 被引量:10
  • 2姜小鹰,胡蓉芳,吴小南,郑翠红.原发性骨质疏松症社区护理干预模式的研究[J].中国实用护理杂志(下旬版),2005,21(1):1-4. 被引量:12
  • 3许良智,庄静,乔林.绝经后骨质疏松性骨折的危险因素及预防[J].实用妇产科杂志,2006,22(7):391-393. 被引量:9
  • 4周松.骨质疏松致脊椎骨折53例疗效分析[J].中国基层医药,2006,13(11):1828-1829. 被引量:4
  • 5[1]Riggs BL.Postmenopausal and senile osteoporosis:current concepts of etiology and treatment[J].Endocrinol Jpn,1979,26Suppl:31-41.
  • 6[2]Reeve J,Meunier PJ,Parsons JA,et al.Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis:a multicentre trial[J].Br Med J,1980,280(6228):1340-1344.
  • 7[3]Fox J.Developments in parathyroid hormone and related peptides as bone-formation agents[ J ].Curr Opin Pharmacol,2002,2(3):338-344.
  • 8[4]Harris ST,Watts NB,Genant HK,et al.Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis:a randomized controlled trial[ J].JAMA,1999,282(14):1344-1352.
  • 9[5]Lane NE,Sanchez S,Genant HK,et al.Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis[ J ].Osteoporos Int,2000,11(5):434-442.
  • 10[6]Lindsay R,Nieves J,Formica C,et al.Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis[ J].Lancet,1997,350(9077):550-555.

共引文献12

同被引文献40

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部